Tumor associated macrophages and neutrophils in cancer

Immunobiology

Volumn 218, Issue 11, 2013, Pages 1402-1410

  Galdiero, Maria Rosaria ^a,b   Bonavita, Eduardo ^a   Barajon, Isabella ^c   Garlanda, Cecilia ^a   Mantovani, Alberto ^a,c   Jaillon, Sébastien ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer; Inflammation; Macrophages; Neutrophils

Indexed keywords

BETA DEFENSIN 3; CXCL3 CHEMOKINE; EOTAXIN 2; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; RANTES; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; INFLAMMATION; INNATE IMMUNITY; LYMPHANGIOGENESIS; MONOCYTE; NEOPLASM; NEUTROPHIL; PLASTICITY; POLARIZATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR MICROENVIRONMENT;

CANCER; COLORECTAL CANCER; CRC; ECM; EXTRACELLULAR MATRIX; HCC; HEAD AND NECK SQUAMOUS CELLULAR CANCER; HEPATOCELLULAR CARCINOMA; HNSCC; INFLAMMATION; MACROPHAGES; MATRIX METALLOPROTEASES; MDSC; MMP; MYELOID DERIVED SUPPRESSOR CELLS; NEUTROPHILS; TAM; TAN; TEN; TUMOR ASSOCIATE NEUTROPHILS; TUMOR ASSOCIATED MACROPHAGES; TUMOR ENTRAINED NEUTROPHILS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

CELL DIFFERENTIATION; CELL MOVEMENT; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; NEOPLASM METASTASIS; NEOPLASMS; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 84884151496     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.06.003     Document Type: Article

References (151)

1. Ai S., Cheng X.W., Inoue A., Nakamura K., Okumura K., Iguchi A., Murohara T., Kuzuya M. Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase. Biochem. Biophys. Res. Commun. 2007, 364:395.
2. Allavena P., Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin. Exp. Immunol. 2012, 167:195.
3. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 2008, 66:1.
4. Aoyagi Y., Oda T., Kinoshita T., Nakahashi C., Hasebe T., Ohkohchi N., Ochiai A. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br. J. Cancer 2004, 91:1316.
5. Ardi V.C., Kupriyanova T.A., Deryugina E.I., Quigley J.P. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20262.
6. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004, 4:540.
7. Beatty G.L., Chiorean E.G., Fishman M.P., Saboury B., Teitelbaum U.R., Sun W., Huhn R.D., Song W., Li D., Sharp L.L., Torigian D.A., O'Dwyer P.J., Vonderheide R.H. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011, 331:1612.
8. Bierie B., Moses H.L. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 2010, 21:49.
9. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 2002, 196:254.
10. Biswas S.K., Gangi L., Paul S., Schioppa T., Saccani A., Sironi M., Bottazzi B., Doni A., Vincenzo B., Pasqualini F., Vago L., Nebuloni M., Mantovani A., Sica A. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006, 107:2112.
11. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889.
12. Bohrer L.R., Schwertfeger K.L. Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner. Mol. Cancer Res. 2012, 10:1294.
13. Bottazzi B., Polentarutti N., Balsari A., Boraschi D., Ghezzi P., Salmona M., Mantovani A. Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int. J. Cancer 1983, 31:55.
14. Brandau S., Moses K., Lang S. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?. Semin. Cancer Biol. 2013, 23:171.
15. Bronte V., Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005, 5:641.
16. Buddingh E.P., Kuijjer M.L., Duim R.A., Burger H., Agelopoulos K., Myklebost O., Serra M., Mertens F., Hogendoorn P.C., Lankester A.C., Cleton-Jansen A.M. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin. Cancer Res. 2011, 17:2110.
17. Caruso R.A., Bellocco R., Pagano M., Bertoli G., Rigoli L., Inferrera C. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod. Pathol. 2002, 15:831.
18. Cassatella M.A. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J. Leukoc. Biol. 2006, 79:1140.
19. Cassatella M.A., Locati M., Mantovani A. Never underestimate the power of a neutrophil. Immunity 2009, 31:698.
20. Chang C.I., Liao J.C., Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. 2001, 61:1100.
21. Chavakis T., Cines D.B., Rhee J.S., Liang O.D., Schubert U., Hammes H.P., Higazi A.A., Nawroth P.P., Preissner K.T., Bdeir K. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J. 2004, 18:1306.
22. Chen C., Qu Q.X., Shen Y., Mu C.Y., Zhu Y.B., Zhang X.G., Huang J.A. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Cancer Lett. 2012, 317:99.
23. Chen C., Shen Y., Qu Q.X., Chen X.Q., Zhang X.G., Huang J.A. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Exp. Cell Res. 2013, 319:96.
24. Citro A., Cantarelli E., Maffi P., Nano R., Melzi R., Mercalli A., Dugnani E., Sordi V., Magistretti P., Daffonchio L., Ruffini P.A., Allegretti M., Secchi A., Bonifacio E., Piemonti L. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. J. Clin. Invest. 2012, 122:3647.
25. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263.
26. Cortez-Retamozo V., Etzrodt M., Newton A., Rauch P.J., Chudnovskiy A., Berger C., Ryan R.J., Iwamoto Y., Marinelli B., Gorbatov R., Forghani R., Novobrantseva T.I., Koteliansky V., Figueiredo J.L., Chen J.W., Anderson D.G., Nahrendorf M., Swirski F.K., Weissleder R., Pittet M.J. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2491.
27. Cortez-Retamozo V., Etzrodt M., Newton A., Ryan R., Pucci F., Sio S.W., Kuswanto W., Rauch P.J., Chudnovskiy A., Iwamoto Y., Kohler R., Marinelli B., Gorbatov R., Wojtkiewicz G., Panizzi P., Mino-Kenudson M., Forghani R., Figueiredo J.L., Chen J.W., Xavier R., Swirski F.K., Nahrendorf M., Weissleder R., Pittet M.J. Angiotensin II drives the production of tumor-promoting macrophages. Immunity 2013, 38:296.
28. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860.
29. Davey M.S., Tamassia N., Rossato M., Bazzoni F., Calzetti F., Bruderek K., Sironi M., Zimmer L., Bottazzi B., Mantovani A., Brandau S., Moser B., Eberl M., Cassatella M.A. Failure to detect production of IL-10 by activated human neutrophils. Nat. Immunol. 2011, 12:1017.
30. De Larco J.E., Wuertz B.R., Furcht L.T. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin. Cancer Res. 2004, 10:4895.
31. De Palma M., Mazzieri R., Politi L.S., Pucci F., Zonari E., Sitia G., Mazzoleni S., Moi D., Venneri M.A., Indraccolo S., Falini A., Guidotti L.G., Galli R., Naldini L. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 2008, 14:299.
32. De Santo C., Arscott R., Booth S., Karydis I., Jones M., Asher R., Salio M., Middleton M., Cerundolo V. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol. 2010, 11:1039.
33. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91.
34. Doedens A.L., Stockmann C., Rubinstein M.P., Liao D., Zhang N., DeNardo D.G., Coussens L.M., Karin M., Goldrath A.W., Johnson R.S. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 2010, 70:7465.
35. Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol 2013, 23:200.
36. Duluc D., Corvaisier M., Blanchard S., Catala L., Descamps P., Gamelin E., Ponsoda S., Delneste Y., Hebbar M., Jeannin P. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 2009, 125:367.
37. Dumitru C.A., Bankfalvi A., Gu X., Eberhardt W.E., Zeidler R., Lang S., Brandau S. Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma. Front. Immunol. 2013, 4:33.
38. Dumitru C.A., Fechner M.K., Hoffmann T.K., Lang S., Brandau S. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. J. Leukoc. Biol. 2012, 91:591.
39. Dumitru C.A., Gholaman H., Trellakis S., Bruderek K., Dominas N., Gu X., Bankfalvi A., Whiteside T.L., Lang S., Brandau S. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int. J. Cancer 2011, 129:859.
40. Ebrahem Q., Chaurasia S.S., Vasanji A., Qi J.H., Klenotic P.A., Cutler A., Asosingh K., Erzurum S., Anand-Apte B. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am. J. Pathol. 2010, 176:496.
41. Edwards J.P., Emens L.A. The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE(2) in murine macrophages. Int. Immunopharmacol. 2010, 10:1220.
42. Erreni M., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron. 2011, 4:141.
43. Fossati G., Ricevuti G., Edwards S.W., Walker C., Dalton A., Rossi M.L. Neutrophil infiltration into human gliomas. Acta Neuropathol. 1999, 98:349.
44. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., Worthen G.S., Albelda S.M. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183.
45. Fridlender Z.G., Sun J., Mishalian I., Singhal S., Cheng G., Kapoor V., Horng W., Fridlender G., Bayuh R., Worthen G.S., Albelda S.M. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS ONE 2012, 7:e31524.
46. Gabrilovich D.I., Bronte V., Chen S.H., Colombo M.P., Ochoa A., Ostrand-Rosenberg S., Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007, 67:425. author reply 426.
47. Geng S., Matsushima H., Okamoto T., Yao Y., Lu R., Page K., Blumenthal R.M., Ward N.L., Miyazaki T., Takashima A. Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood 2013, 121:1690.
48. Germano G., Frapolli R., Belgiovine C., Anselmo A., Pesce S., Liguori M., Erba E., Uboldi S., Zucchetti M., Pasqualini F., Nebuloni M., van Rooijen N., Mortarini R., Beltrame L., Marchini S., Fuso Nerini I., Sanfilippo R., Casali P.G., Pilotti S., Galmarini C.M., Anichini A., Mantovani A., D'Incalci M., Allavena P. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell 2013, 23:249.
49. Gocheva V., Wang H.W., Gadea B.B., Shree T., Hunter K.E., Garfall A.L., Berman T., Joyce J.A. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010, 24:241.
50. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953.
51. Gorelik E., Wiltrout R.H., Brunda M.J., Holden H.T., Herberman R.B. Augmentation of metastasis formation by thioglycollate-elicited macrophages. Int. J. Cancer 1982, 29:575.
52. Granata F., Frattini A., Loffredo S., Staiano R.I., Petraroli A., Ribatti D., Oslund R., Gelb M.H., Lambeau G., Marone G., Triggiani M. Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2. J. Immunol. 2010, 184:5232.
53. Granot Z., Henke E., Comen E.A., King T.A., Norton L., Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011, 20:300.
54. Gregory A.D., Houghton A.M. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011, 71:2411.
55. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., Taniguchi K., Yu G.Y., Osterreicher C.H., Hung K.E., Datz C., Feng Y., Fearon E.R., Oukka M., Tessarollo L., Coppola V., Yarovinsky F., Cheroutre H., Eckmann L., Trinchieri G., Karin M. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254.
56. Grosse-Steffen T., Giese T., Giese N., Longerich T., Schirmacher P., Hansch G.M., Gaida M.M. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. Clin. Dev. Immunol. 2012, 2012:720768.
57. Gungor N., Knaapen A.M., Munnia A., Peluso M., Haenen G.R., Chiu R.K., Godschalk R.W., van Schooten F.J. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010, 25:149.
58. Hagemann T., Wilson J., Burke F., Kulbe H., Li N.F., Pluddemann A., Charles K., Gordon S., Balkwill F.R. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 2006, 176:5023.
59. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646.
60. + tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. Pathol. Int. 2008, 58:529.
61. Hotchkiss K.A., Ashton A.W., Klein R.S., Lenzi M.L., Zhu G.H., Schwartz E.L. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res. 2003, 63:527.
62. Houghton A.M., Rzymkiewicz D.M., Ji H., Gregory A.D., Egea E.E., Metz H.E., Stolz D.B., Land S.R., Marconcini L.A., Kliment C.R., Jenkins K.M., Beaulieu K.A., Mouded M., Frank S.J., Wong K.K., Shapiro S.D. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 2010, 16:219.
63. Huang S., Van Arsdall M., Tedjarati S., McCarty M., Wu W., Langley R., Fidler I.J. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J. Natl. Cancer Inst. 2002, 94:1134.
64. Huh S.J., Liang S., Sharma A., Dong C., Robertson G.P. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res. 2010, 70:6071.
65. Imai Y., Kubota Y., Yamamoto S., Tsuji K., Shimatani M., Shibatani N., Takamido S., Matsushita M., Okazaki K. Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study. J. Gastroenterol. Hepatol. 2005, 20:287.
66. Jablonska J., Leschner S., Westphal K., Lienenklaus S., Weiss S. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 2010, 120:1151.
67. Jamieson T., Clarke M., Steele C.W., Samuel M.S., Neumann J., Jung A., Huels D., Olson M.F., Das S., Nibbs R.J., Sansom O.J. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 2012, 122:3127.
68. Jensen H.K., Donskov F., Marcussen N., Nordsmark M., Lundbeck F., von der Maase H. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 2009, 27:4709.
69. Jin G., Kawsar H.I., Hirsch S.A., Zeng C., Jia X., Feng Z., Ghosh S.K., Zheng Q.Y., Zhou A., McIntyre T.M., Weinberg A. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS ONE 2010, 5:e10993.
70. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239.
71. Keeley E.C., Mehrad B., Strieter R.M. CXC chemokines in cancer angiogenesis and metastases. Adv. Cancer Res. 2010, 106:91.
72. Kemp T.J., Ludwig A.T., Earel J.K., Moore J.M., Vanoosten R.L., Moses B., Leidal K., Nauseef W.M., Griffith T.S. Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Blood 2005, 106:3474.
73. Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., Brumlik M., Cheng P., Curiel T., Myers L., Lackner A., Alvarez X., Ochoa A., Chen L., Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 2006, 203:871.
74. Kuang D.M., Zhao Q., Peng C., Xu J., Zhang J.P., Wu C., Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 2009, 206:1327.
75. Kuang D.M., Zhao Q., Wu Y., Peng C., Wang J., Xu Z., Yin X.Y., Zheng L. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 2011, 54:948.
76. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 2010, 16:133.
77. Leifler K.S., Svensson S., Abrahamsson A., Bendrik C., Robertson J., Gauldie J., Olsson A.K., Dabrosin C. Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer. J Immunol 2013, 190:4420.
78. Li D., Wang X., Wu J.L., Quan W.Q., Ma L., Yang F., Wu K.Y., Wan H.Y. Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. PLoS ONE 2013, 8:e56616.
79. Lin E.Y., Gouon-Evans V., Nguyen A.V., Pollard J.W. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland Biol. Neoplasia 2002, 7:147.
80. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., Qian H., Xue X.N., Pollard J.W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006, 66:11238.
81. Lin J.Y., Li X.Y., Tadashi N., Dong P. Clinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinoma. Chin. J. Cancer 2011, 30:280.
82. Linde N., Lederle W., Depner S., van Rooijen N., Gutschalk C.M., Mueller M.M. Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. J. Pathol. 2012, 227:17.
83. Mantovani A. The yin-yang of tumor-associated neutrophils. Cancer Cell 2009, 16:173.
84. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436.
85. Mantovani A., Allavena P., Sozzani S., Vecchi A., Locati M., Sica A. Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin. Cancer Biol. 2004, 14:155.
86. Mantovani A., Bottazzi B., Colotta F., Sozzani S., Ruco L. The origin and function of tumor-associated macrophages. Immunol. Today 1992, 13:265.
87. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519.
88. Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 2010, 22:231.
89. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549.
90. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303.
91. Matsui A., Yokoo H., Negishi Y., Endo-Takahashi Y., Chun N.A., Kadouchi I., Suzuki R., Maruyama K., Aramaki Y., Semba K., Kobayashi E., Takahashi M., Murakami T. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80-cells and promotes tumor progression. PLoS ONE 2012, 7:e44080.
92. Matsushima H., Geng S., Lu R., Okamoto T., Yao Y., Mayuzumi N., Kotol P.F., Chojnacki B.J., Miyazaki T., Gallo R.L., Takashima A. Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood 2013, 121:1677.
93. Mittendorf E.A., Alatrash G., Qiao N., Wu Y., Sukhumalchandra P., St John L.S., Philips A.V., Xiao H., Zhang M., Ruisaard K., Clise-Dwyer K., Lu S., Molldrem J.J. Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response. Cancer Res. 2012, 72:3153.
94. Movahedi K., Laoui D., Gysemans C., Baeten M., Stange G., Van den Bossche J., Mack M., Pipeleers D., In't Veld P., De Baetselier P., Van Ginderachter J.A. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010, 70:5728.
95. Murdoch C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104:2224.
96. Murdoch C., Muthana M., Coffelt S.B., Lewis C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8:618.
97. Nagakawa Y., Aoki T., Kasuya K., Tsuchida A., Koyanagi Y. Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas 2002, 24:169.
98. Neyen C., Pluddemann A., Mukhopadhyay S., Maniati E., Bossard M., Gordon S., Hagemann T. Macrophage Scavenger Receptor A Promotes Tumor Progression in Murine Models of Ovarian and Pancreatic Cancer. J Immunol 2013, 190:3798.
99. Noel W., Raes G., Hassanzadeh Ghassabeh G., De Baetselier P., Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004, 20:126.
100. Nozawa H., Chiu C., Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12493.
101. Oehler L., Majdic O., Pickl W.F., Stockl J., Riedl E., Drach J., Rappersberger K., Geissler K., Knapp W. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J. Exp. Med. 1998, 187:1019.
102. Ohno S., Inagawa H., Dhar D.K., Fujii T., Ueda S., Tachibana M., Suzuki N., Inoue M., Soma G., Nagasue N. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res. 2003, 23:5015.
103. Peng H.H., Liang S., Henderson A.J., Dong C. Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. Exp. Cell Res. 2007, 313:551.
104. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238.
105. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39.
106. Qing W., Fang W.Y., Ye L., Shen L.Y., Zhang X.F., Fei X.C., Chen X., Wang W.Q., Li X.Y., Xiao J.C., Ning G. Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 2012, 22:905.
107. Queen M.M., Ryan R.E., Holzer R.G., Keller-Peck C.R., Jorcyk C.L. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 2005, 65:8896.
108. Rao H.L., Chen J.W., Li M., Xiao Y.B., Fu J., Zeng Y.X., Cai M.Y., Xie D. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS ONE 2012, 7:e30806.
109. Reed J.R., Stone M.D., Beadnell T.C., Ryu Y., Griffin T.J., Schwertfeger K.L. Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent manner. PLoS ONE 2012, 7:e45877.
110. Reid M.D., Basturk O., Thirabanjasak D., Hruban R.H., Klimstra D.S., Bagci P., Altinel D., Adsay V. Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod. Pathol. 2011, 24:1612.
111. Romagnani P., De Paulis A., Beltrame C., Annunziato F., Dente V., Maggi E., Romagnani S., Marone G. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am. J. Pathol. 1999, 155:1195.
112. Rozel S., Galban C.J., Nicolay K., Lee K.C., Sud S., Neeley C., Snyder L.A., Chenevert T.L., Rehemtulla A., Ross B.D., Pienta K.J. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J. Cell. Biochem. 2009, 107:58.
113. Sandhu J.K., Privora H.F., Wenckebach G., Birnboim H.C. Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am. J. Pathol. 2000, 156:509.
114. Scapini P., Morini M., Tecchio C., Minghelli S., Di Carlo E., Tanghetti E., Albini A., Lowell C., Berton G., Noonan D.M., Cassatella M.A. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 2004, 172:5034.
115. Scapini P., Nesi L., Morini M., Tanghetti E., Belleri M., Noonan D., Presta M., Albini A., Cassatella M.A. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J. Immunol. 2002, 168:5798.
116. Schmidt T., Carmeliet P. Blood-vessel formation: bridges that guide and unite. Nature 2010, 465:697.
117. Schoppmann S.F., Birner P., Stockl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 2002, 161:947.
118. Shojaei F., Singh M., Thompson J.D., Ferrara N. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2640.
119. Shojaei F., Wu X., Qu X., Kowanetz M., Yu L., Tan M., Meng Y.G., Ferrara N. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6742.
120. Shojaei F., Wu X., Zhong C., Yu L., Liang X.H., Yao J., Blanchard D., Bais C., Peale F.V., van Bruggen N., Ho C., Ross J., Tan M., Carano R.A., Meng Y.G., Ferrara N. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007, 450:825.
121. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787.
122. Sica A., Saccani A., Bottazzi B., Polentarutti N., Vecchi A., van Damme J., Mantovani A. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 2000, 164:762.
123. Solinas G., Schiarea S., Liguori M., Fabbri M., Pesce S., Zammataro L., Pasqualini F., Nebuloni M., Chiabrando C., Mantovani A., Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 2010, 185:642.
124. Stetler-Stevenson W.G., Yu A.E. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 2001, 11:143.
125. Suttmann H., Riemensberger J., Bentien G., Schmaltz D., Stockle M., Jocham D., Bohle A., Brandau S. Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res. 2006, 66:8250.
126. Tamassia N., Zimmermann M., Castellucci M., Ostuni R., Bruderek K., Schilling B., Brandau S., Bazzoni F., Natoli G., Cassatella M.A. Cutting edge: an inactive chromatin configuration at the IL-10 locus in human neutrophils. J. Immunol. 2013, 190:1921.
127. Tanaka H., Ito T., Kyo T., Kimura A. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. Eur. J. Haematol. 2007, 78:389.
128. Tazawa H., Okada F., Kobayashi T., Tada M., Mori Y., Une Y., Sendo F., Kobayashi M., Hosokawa M. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol. 2003, 163:2221.
129. Tecchio C., Huber V., Scapini P., Calzetti F., Margotto D., Todeschini G., Pilla L., Martinelli G., Pizzolo G., Rivoltini L., Cassatella M.A. IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. Blood 2004, 103:3837.
130. Tecchio C., Scapini P., Pizzolo G., Cassatella M.A. On the cytokines produced by human neutrophils in tumors. Semin. Cancer Biol. 2013, 23:159.
131. Tosello Boari J., Amezcua Vesely M.C., Bermejo D.A., Ramello M.C., Montes C.L., Cejas H., Gruppi A., Acosta Rodriguez E.V. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog. 2012, 8:e1002658.
132. Trellakis S., Bruderek K., Dumitru C.A., Gholaman H., Gu X., Bankfalvi A., Scherag A., Hutte J., Dominas N., Lehnerdt G.F., Hoffmann T.K., Lang S., Brandau S. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 2011, 129:2183.
133. Tsuda Y., Fukui H., Asai A., Fukunishi S., Miyaji K., Fujiwara S., Teramura K., Fukuda A., Higuchi K. An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma. J. Clin. Biochem. Nutr. 2012, 51:204.
134. Tsuda Y., Takahashi H., Kobayashi M., Hanafusa T., Herndon D.N., Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004, 21:215.
135. Ueno T., Toi M., Saji H., Muta M., Bando H., Kuroi K., Koike M., Inadera H., Matsushima K. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 2000, 6:3282.
136. van Egmond M., Bakema J.E. Neutrophils as effector cells for antibody-based immunotherapy of cancer. Semin. Cancer Biol. 2012, 23:190.
137. Vasiljeva O., Papazoglou A., Kruger A., Brodoefel H., Korovin M., Deussing J., Augustin N., Nielsen B.S., Almholt K., Bogyo M., Peters C., Reinheckel T. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 2006, 66:5242.
138. Wang F.Q., So J., Reierstad S., Fishman D.A. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int. J. Cancer 2005, 114:19.
139. Wang R., Zhang J., Chen S., Lu M., Luo X., Yao S., Liu S., Qin Y., Chen H. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. Lung Cancer 2011, 74:188.
140. Wijelath E.S., Carlsen B., Cole T., Chen J., Kothari S., Hammond W.P. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J. Cell Sci. 1997, 110(Pt 7):871.
141. Wislez M., Rabbe N., Marchal J., Milleron B., Crestani B., Mayaud C., Antoine M., Soler P., Cadranel J. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res. 2003, 63:1405.
142. Xin H., Zhang C., Herrmann A., Du Y., Figlin R., Yu H. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 2009, 69:2506.
143. Ye X.Z., Xu S.L., Xin Y.H., Yu S.C., Ping Y.F., Chen L., Xiao H.L., Wang B., Yi L., Wang Q.L., Jiang X.F., Yang L., Zhang P., Qian C., Cui Y.H., Zhang X., Bian X.W. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 2012, 189:444.
144. Youn J.I., Kumar V., Collazo M., Nefedova Y., Condamine T., Cheng P., Villagra A., Antonia S., McCaffrey J.C., Fishman M., Sarnaik A., Horna P., Sotomayor E., Gabrilovich D.I. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 2013, 14:211.
145. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., Schwendener R.A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 2006, 95:272.
146. Zhang J., Sud S., Mizutani K., Gyetko M.R., Pienta K.J. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model. Neoplasia 2011, 13:23.
147. Zhang Q.W., Liu L., Gong C.Y., Shi H.S., Zeng Y.H., Wang X.Z., Zhao Y.W., Wei Y.Q. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE 2012, 7:e50946.
148. Zhang X., Majlessi L., Deriaud E., Leclerc C., Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009, 31:761.
149. Zhao J.J., Pan K., Wang W., Chen J.G., Wu Y.H., Lv L., Li J.J., Chen Y.B., Wang D.D., Pan Q.Z., Li X.D., Xia J.C. The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS ONE 2012, 7:e33655.
150. + T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J. Immunol. 2012, 188:1117.
151. Zhou S.L., Dai Z., Zhou Z.J., Wang X.Y., Yang G.H., Wang Z., Huang X.W., Fan J., Zhou J. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012, 56:2242.